Supreme Court Won’t Revive Medical Product Company’s Challenge to Rescinded CMS Policy
- October 25, 2024
The manufacturer of medical products containing human cells, tissues, or cellular or tissue-based products lost its bid to revive its challenge to a now rescinded Centers for Medicare & Medicaid Services (CMS) automatic-denial of reimbursement policy.
ARTICLE TAGS
You must be logged in to access this content.